Immunocore Holdings (IMCR) Inventory Average (2022 - 2026)

Immunocore Holdings (IMCR) has reported Inventory Average for 4 consecutive years, with $7.5 million the latest figure, recorded in Q1 2026.

• Quarterly Inventory Average rose 22.41% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 22.41% YoY) and the FY2025 annual result came in at $6.1 million, up 22.53% from the prior year.
• Inventory Average rose to $7.5 million in Q1 2026 per IMCR's latest filing, from $6.2 million in the prior quarter.
• Over the last five years, Inventory Average for IMCR reached as high as $7.5 million in Q1 2026 and fell as low as $1.1 million in Q4 2022.
• A 4-year average of $5.0 million and a median of $5.3 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2025 — Inventory Average jumped 60.7% — and 2026, when it advanced 22.41%.
• Year by year, Inventory Average stood at $1.1 million in 2022, then surged by 371.66% to $5.0 million in 2024, then advanced by 24.42% to $6.2 million in 2025, then rose by 20.96% to $7.5 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $7.5 million, $6.2 million, and $5.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.